Memphis Pharmaceuticals & Chemical Industries reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was EGP 551.26 million compared to EGP 518.11 million a year ago. Net income was EGP 74.09 million compared to EGP 41.81 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
80.28 EGP | -5.66% | -15.72% | +28.02% |
1st Jan change | Capi. | |
---|---|---|
+28.02% | 9.53M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022